Hormone Receptor Positive Breast Adenocarcinoma
7 clinical trials · Condition
◉ Watch Hormone Receptor Positive Breast Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer (NCT04481113) | OHSU Knight Cancer Institute | 2021-06-07 |
| Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial (NCT04756505) | M.D. Anderson Cancer Center | 2021-03-07 |
| Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases (NCT04789668) | M.D. Anderson Cancer Center | 2021-01-15 |
| Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand (NCT04876378) | University of California, San Francisco | 2020-05-18 |
Track Hormone Receptor Positive Breast Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.